BioBridgeXAll companies

Dianthus Therapeutics, Inc. /DE/

Pharmaceutical company · New York, United States · Nasdaq: DNTH

Dianthus Therapeutics, Inc. /DE/ is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker DNTH. It has reported private securities offerings to the US SEC, most recently $52 million sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Dianthus Therapeutics, Inc. /DE/ at a glance

Typepharmaceutical company
HeadquartersNew York, United States
Earliest incorporation on record2015
Stock listingNasdaq: DNTH
SEC industryPharmaceutical Preparations
SEC CIK1690585

What does Dianthus Therapeutics, Inc. /DE/ do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $52.3 million sold (2018).

Frequently asked questions about Dianthus Therapeutics, Inc. /DE/

Where is Dianthus Therapeutics, Inc. /DE/ headquartered?

Dianthus Therapeutics, Inc. /DE/ is headquartered in New York, United States.

What does Dianthus Therapeutics, Inc. /DE/ do?

Dianthus Therapeutics, Inc. /DE/ is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Dianthus Therapeutics, Inc. /DE/ a public company?

Yes. Dianthus Therapeutics, Inc. /DE/ trades on Nasdaq under the ticker DNTH.

When was Dianthus Therapeutics, Inc. /DE/ founded?

The earliest incorporation on record for Dianthus Therapeutics, Inc. /DE/ is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.